PATENT CLAIM ANALYSIS

Application Number: 15905485
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "287000"]

Abstract:
The invention provides novel nicotinic acetylcholine receptor agonists, for example, phantasmidine and derivatives thereof, for example a compound of formula I. Also disclosed are methods of treating disorders responsive to nicotinic acetylcholine receptor agonists such as Alzheimer's disease, schizophrenia, Myasthenia Gravis, Tourette's syndrome, Parkinson's disease, epilepsy, pain, and cognitive dysfunction by treatment with the nicotinic acetylcholine receptor agonists.

Claim (Index 49):
The method of  claim 46 , wherein the compound is of formula (I) and R 1  is CH 3 CO.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 88.0
- Lexical Diversity: 1.52083
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14695460', '13583420', '10703153', '12197735', '15162237']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7221830241035727
- 35 USC 102 Novelty (BERT): 0.5157177994909682
- Combined Prediction Score: 0.7015365016423123
- Mean Citation Score: 199.323564
- Max Citation Score: 274.91644
- Similarity Product: 203.77657802227023

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test